Know Cancer

or
forgot password

Evaluation of a Multispectral Vision Enhancement System for Assessment of Oral Mucosal Lesions


N/A
18 Years
N/A
Not Enrolling
Both
Oral Cancer

Thank you

Trial Information

Evaluation of a Multispectral Vision Enhancement System for Assessment of Oral Mucosal Lesions


All tissue and cells are made of tiny particles that give off small amounts of light. This
light is called fluorescence. Scientists have learned that cancerous cells and normal cells
give off different amounts and different types of fluorescence. Scientists need to better
understand whether fluorescence from the oral cavity (mouth) can be used to tell which cells
are abnormal. This information can help doctors detect pre-cancers.

In order to better understand fluorescence, researchers at the Optical Spectroscopy and
Imaging Lab, Department of Bioengineering, Rice University have developed an instrument that
can collect and analyze fluorescence without surgically removing any tissue or touching the
tissue. This instrument takes pictures of oral cavity fluorescence through a microscope.
The instrument also takes regular live pictures. Scientists hope to study the pictures to
better understand the differences in fluorescence from normal and abnormal cells. The
instrument is a standard medical microscope similar to ones used by doctors in their offices
to examine people's ears. Researchers have attached a special light source to the
microscope that provides different colors of light. In addition, the microscope has a
digital camera attached to it so that the researchers can record what they see with the
different light colors.

In this study, a clinician will use the instrument to take pictures of suspicious and normal
oral cavity lesions. A small sample of the oral lesion (2-4 mm each, the size of a small
eraser) will be removed or biopsied from the areas that are imaged. A portion of both the
suspicious and normal areas will be taken to pathology for evaluation. The biopsy from the
normal appearing area is a biopsy that is additional to those you will receive as part of
your standard of care. Each participant will have 2-4 biopsies performed, depending upon
how many areas the examiner feels may be suspicious. Most people who take part in this
study will be having surgery to remove lesions in the oral cavity anyway, so the biopsies
will be performed at the time of surgery. For those participants who are not scheduled to
have surgery, the biopsies will be performed under local anesthesia in the clinic.

All data will be numerically coded to ensure your confidentiality.

In addition to the pictures taken and the biopsy, a brief interview will be performed by the
clinical research staff to discuss possible past local therapies and your personal history
of tobacco and alcohol use. The interview should take about 10 minutes to complete.

You will not be told of any of the experimental findings. Information confirming the
diagnosis will be made available to your treating physician. After this visit and tissue
collection, your participation in this study will be complete.

This is an investigational study. A total of 45 patients will take part in this study. All
will be enrolled at M. D. Anderson.


Inclusion Criteria:



1. Subjects with lesions of the oral cavity mucosa or suspicious for malignancy or
premalignancy.

2. Subjects with the ability and willingness to sign an informed consent and
authorization.

3. Subjects who develop new lesions or alterations in long-standing lesions are
eligible, but not required, for re-examination with informed consent.

Exclusion Criteria:

1. Persons who are medically unfit to undergo superficial punch biopsies of oral mucosa.

2. Persons under the age of 18.

Type of Study:

Observational

Study Design:

Observational Model: Case-Only, Time Perspective: Prospective

Outcome Measure:

Evaluate new imaging technology, MDM (Multispectral Digital Microscope), as a tool for early diagnosis of oral neoplasia

Outcome Time Frame:

4 Years

Safety Issue:

No

Principal Investigator

Ann M. Gillenwater, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

M.D. Anderson Cancer Center

Authority:

United States: Institutional Review Board

Study ID:

2004-0684

NCT ID:

NCT00502580

Start Date:

July 2005

Completion Date:

March 2008

Related Keywords:

  • Oral Cancer
  • Oral Cancer
  • Multispectral Digital Microscope
  • Multispectral Digital Imaging
  • Interview
  • MDM
  • Mouth Neoplasms
  • Lip Neoplasms

Name

Location

U.T.M.D. Anderson Cancer Center Houston, Texas  77030